Ebru Şen

6PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Radiologic Axillary Response After Neoadjuvant Chemotherapy in cN2 Breast Cancer: Decision Support for Selective Axillary De-Escalation.

|Feb 27, 2026
Predictive Role of Pre-Radiotherapy D-Dimer and Inflammatory Markers in Monitoring Outcomes After Treatment in Hormone-Positive Breast Cancer: A Retrospective Cohort Study.

Kimia Cepni, Tugce Hilal Ucgun, Tugce Dursun Ucar

|Jan 28, 2026
Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy.

Şahin Bedir, Uğur Alp Yeşilova, Merve Tokoçin

|Jan 25, 2025
Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment?

Ebru Sen, Mehmet Ali Nazlı, Göktürk Maralcan

|Dec 27, 2024
Perivascular Invasion: A Promising Prognostic Parameter for Breast Cancer.

Begüm Çalım Gürbüz, Tuçe Söylemez Akkurt, Handan Eren

|Oct 23, 2023
Investigation of Clinical Histopathologic Features and Metabolic Parameters of 18F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component.

Elife Akgün, Göksel Alçın, Esra Canan Kelten Talu

Pageof 1

Frequent Collaborators

3 joint publications

Gökmen Umut Erdem

2 joint publications

Tuçe Söylemez Akkurt

2 joint publications

Mehmet Ali Nazlı

1 joint publications

Elife Akgün